Alemtuzumab has a durable effect on disability improvement in treatment-naive patients with relapsing-remitting multiple sclerosis: a 4-year follow-up of CARE-MS I

Affiliation auteursAffiliation ok
TitreAlemtuzumab has a durable effect on disability improvement in treatment-naive patients with relapsing-remitting multiple sclerosis: a 4-year follow-up of CARE-MS I
Type de publicationJournal Article
Year of Publication2015
AuteursO. Fernandez F, Hartung H-P, Laganke C., Margolin D.H, Kasten L., Moreau T., Giovannoni G.
JournalEUROPEAN JOURNAL OF NEUROLOGY
Volume22
Pagination824
Date PublishedJUN
Type of ArticleMeeting Abstract
ISSN1351-5101